p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time (Q41815072)

12 October 2017

p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time (English)

1 reference

12 October 2017

1

1 reference

12 October 2017

Pezzella F

2

1 reference

12 October 2017

Martinez-Montero JC

3

1 reference

12 October 2017

Orradre JL

4

1 reference

12 October 2017

Villuendas R

5

1 reference

12 October 2017

Sanchez-Beato M

6

1 reference

12 October 2017

Cuena R

7

1 reference

12 October 2017

Cruz MA

8

1 reference

12 October 2017

Martinez B

9

1 reference

12 October 2017

Pezella F [corrected to Pezzella F

10

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 February 1994

1 reference

British Journal of Cancer

12 October 2017

1 reference

12 October 2017

69

1 reference

12 October 2017

337-341

1 reference

12 October 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.61

12 October 2017

0 references

cites work

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

A genetic model for colorectal tumorigenesis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

p53: oncogene or anti-oncogene?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

p53 is frequently mutated in Burkitt's lymphoma cell lines

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Chromosome 17- and p53 changes in lymphoma.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Cooperative interaction between c-myc and bcl-2 proto-oncogenes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Clonal expansion of p53 mutant cells is associated with brain tumour progression

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Cancer and ageing in mice and men

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Thymocyte apoptosis induced by p53-dependent and independent pathways.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968699

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

18 August 2018

1 reference

12 December 2020

Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms

1 reference

12 December 2020

Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas

1 reference

12 December 2020

Mutations of p53 gene and their relation to disease progression in B-cell lymphoma

1 reference

12 December 2020

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

12 December 2020

P53 protein expression in lymphomas and reactive lymphoid tissue

1 reference

12 December 2020

High levels of p53 protein in UV-irradiated normal human skin

1 reference

12 December 2020

Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma

1 reference

12 December 2020

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

12 December 2020

Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma

1 reference

12 December 2020

The bcl-2 gene is rearranged in many diffuse B-cell lymphomas

1 reference

12 December 2020

bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma

1 reference

12 December 2020

Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma

1 reference

12 December 2020

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.61

1 reference

Dimensions Publication ID

12 October 2017

0 references

1 reference

12 October 2017

1 reference